Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Eudesmin shows antiinflammatory, neuritogenic, anticonvulsant and sedative effects, the mechanism of eudesmin may be related to up-regulation of GABAA and GAD65 expressions, and anti-apoptosis of neuron the in brain.50 microM (+)-eudesmin can induce neurite outgrowth and enhance nerve growth factor (NGF)-mediated neurite outgrowth from PC12 cells by stimulating up-stream MAPK, PKC and PKA pathways.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 43,000 | |||
5 mg | 在庫あり | ¥ 105,500 | |||
10 mg | 在庫あり | ¥ 155,500 | |||
25 mg | 在庫あり | ¥ 243,500 | |||
50 mg | 在庫あり | ¥ 328,500 | |||
100 mg | 在庫あり | ¥ 443,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 108,000 |
説明 | Eudesmin shows antiinflammatory, neuritogenic, anticonvulsant and sedative effects, the mechanism of eudesmin may be related to up-regulation of GABAA and GAD65 expressions, and anti-apoptosis of neuron the in brain.50 microM (+)-eudesmin can induce neurite outgrowth and enhance nerve growth factor (NGF)-mediated neurite outgrowth from PC12 cells by stimulating up-stream MAPK, PKC and PKA pathways. |
植物由来 |
分子量 | 386.44 |
分子式 | C22H26O6 |
CAS No. | 526-06-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 25 mg/mL (64.69 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Eudesmin 526-06-7 MAPK PI3K/Akt/mTOR signaling S6 Kinase Ribosomal S6 Kinase (RSK) S6K obesity diseases Adipogenesis S6K1 Eudesmine Inhibitor metabolic inhibit inhibitor